Your browser doesn't support javascript.
loading
SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine.
Etemadifar, Masoud; Sedaghat, Nahad; Nouri, Hosein; Lotfi, Noushin; Chitsaz, Ahmad; Khorvash, Reza; Zolfaghari, Hamed; Ghasemi Movaghar, Alireza; Pourabbas, Mohammad; Salari, Mehri.
Afiliação
  • Etemadifar M; Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Sedaghat N; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran. Electronic address: nahad.sedaghat@gmail
  • Nouri H; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran.
  • Lotfi N; Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Chitsaz A; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Khorvash R; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Zolfaghari H; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Ghasemi Movaghar A; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Pourabbas M; Biotechnology Research Center, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran.
  • Salari M; Department of Neurology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mult Scler Relat Disord ; 57: 103417, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34875487

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article